Lord, Abbett & Co. LLC Sight Sciences, Inc. Transaction History

Lord, Abbett & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 07, 2024	BUY	$8.44 - $13.35 $911,157 - $1.44 Million	107,957 Added 30.52%	461,739 $4.04 Million
Q1 2023 May 12, 2023	BUY	$8.44 - $13.35 $911,157 - $1.44 Million	107,957 Added 30.52%	461,739 $4.04 Million
Q4 2022 Oct 07, 2024	BUY	$5.58 - $13.94 $1.97 Million - $4.93 Million	353,782 New	353,782 $4.32 Million
Q4 2022 Feb 10, 2023	BUY	$5.58 - $13.94 $1.97 Million - $4.93 Million	353,782 New	353,782 $4.32 Million
Q2 2022 Aug 12, 2022	SELL	$6.61 - $11.99 $814,153 - $1.48 Million	-123,170 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.56 - $17.9 $1.42 Million - $2.2 Million	123,170 New	123,170 $1.42 Million

21.6M

66.8K

13K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $192M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.